Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» · Russian Federation · Est. 2014
ISSN2312-7821eISSN2619-1164
✓ DOAJ✓ Open Access
15
/ 100
High Risk
Score Breakdown
✓ DOAJ Verified+15
Total15
H-Index
9
Total Works
356
Total Citations
733
2yr Mean Citedness
0.64
Free JIF alternative
Aims & Scope✦ Inferred from recent articles
The journal focuses on the safety and efficacy of pharmacotherapy, including the assessment of adverse drug reactions, pharmacogenetics, and the development of personalized treatment strategies. It also covers pharmacovigilance systems, drug development, and regulatory aspects of medicinal products, with a particular emphasis on the Russian Federation.
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
✅
Does the journal have a website?
✓ Linked
✅
Is the ISSN verified?
2312-7821 / 2619-1164
✅
Indexed in a trusted database?
DOAJ
✅
Peer review process documented?
Double anonymous peer review
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
✅
Not on predatory/blacklists?
✓ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
✅
Listed in DOAJ (verified OA)?
DOAJ verified
✅
Primary language documented?
Russian
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Pharmacovigilance and Adverse Drug ReactionsComputational Drug Discovery MethodsLegal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesPharmaceutical studies and practicesPharmaceutical Economics and PolicyDrug-Induced Hepatotoxicity and ProtectionDrug-Induced Adverse ReactionsAcademic Publishing and Open Access